596 related articles for article (PubMed ID: 23422022)
1. Vascular extracellular matrix in atherosclerosis.
Chistiakov DA; Sobenin IA; Orekhov AN
Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
4. [Extracellular matrix, matrix-degrading proteases and vascular calcification].
Du YY; Wang X; Kong W
Sheng Li Ke Xue Jin Zhan; 2008 Jul; 39(3):203-8. PubMed ID: 18819486
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability.
Newby AC
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2108-14. PubMed ID: 18772495
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and atherogenesis in dependence of age.
Kunz J
Gerontology; 2007; 53(2):63-73. PubMed ID: 17047333
[TBL] [Abstract][Full Text] [Related]
7. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Janssens S; Lijnen HR
Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
[TBL] [Abstract][Full Text] [Related]
8. Vascular remodeling and protease inhibition--bench to bedside.
Sluijter JP; de Kleijn DP; Pasterkamp G
Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
[TBL] [Abstract][Full Text] [Related]
9. [Matrix metalloproteinases and atherosclerosis].
Fic P; Zakrocka I; Kurzepa J; Stepulak A
Postepy Hig Med Dosw (Online); 2011 Jan; 65():16-27. PubMed ID: 21357991
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in vascular physiology and disease.
Siefert SA; Sarkar R
Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
12. Collagen and related extracellular matrix proteins in atherosclerotic plaque development.
Shami A; Gonçalves I; Hultgårdh-Nilsson A
Curr Opin Lipidol; 2014 Oct; 25(5):394-9. PubMed ID: 25137612
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
Raffetto JD; Khalil RA
Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
[TBL] [Abstract][Full Text] [Related]
15. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
[TBL] [Abstract][Full Text] [Related]
16. Role of extracellular matrix and its regulators in human airway smooth muscle biology.
Parameswaran K; Willems-Widyastuti A; Alagappan VK; Radford K; Kranenburg AR; Sharma HS
Cell Biochem Biophys; 2006; 44(1):139-46. PubMed ID: 16456242
[TBL] [Abstract][Full Text] [Related]
17. Collagens in the progression and complications of atherosclerosis.
Adiguzel E; Ahmad PJ; Franco C; Bendeck MP
Vasc Med; 2009 Feb; 14(1):73-89. PubMed ID: 19144782
[TBL] [Abstract][Full Text] [Related]
18. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
20. The role of matrix metalloproteinases in the oral environment.
Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]